In conclusion, we revealed that the ABCA1 transporter restrained the chemosensitivity of TMZ and enhanced immune cell infiltration in glioma, intimating that TMZ combined with ABCA1 antagonists was a potential approach to improving the therapeutic efficacy of glioma. Here, ABCA1 is linked to glioma.